AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Income Before Tax Over TimeExpanding
Percentile Rank93
3Y CAGR+14.5%
5Y CAGR+6.2%
Year-over-Year Change
Pre-tax earnings
3Y CAGR
+14.5%/yr
vs +1.0%/yr prior
5Y CAGR
+6.2%/yr
Recent acceleration
Acceleration
+13.5pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $50.66B | +15.7% |
| 2024 | $43.80B | +67.7% |
| 2023 | $26.13B | -22.5% |
| 2022 | $33.73B | -54.1% |
| 2021 | $73.44B | +96.2% |
| 2020 | $37.43B | +21.1% |
| 2019 | $30.91B | -4.6% |
| 2018 | $32.41B | +5.9% |
| 2017 | $30.61B | +11.5% |
| 2016 | $27.44B | - |